Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04620655 | RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL | unknown | N/A | 24 | Min XiangOTHER | 1 | Nov 9, 2020 | clinicaltrials |
| NCT04610125 | Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children | unknown | N/A | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
| Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma |
| unknown |
| N/A |
| 6 |
| Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER |
| 1 |
| Oct 12, 2020 |
| clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03327285 | C-CAR011 Treatment in Subjects With ALL After HSCT | unknown | N/A | 40 | Peking University People's HospitalOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04447547 | Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04447573 | Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 29, 2020 | clinicaltrials |
| NCT04546893 | Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04546906 | Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04511351 | Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma | unknown | N/A | 76 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT04497688 | Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma | unknown | N/A | 104 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 4, 2020 | clinicaltrials |
| NCT04497701 | Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies | unknown | N/A | 139 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 4, 2020 | clinicaltrials |
| NCT04496011 | Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation | unknown | N/A | 30 | Federal University of Health Science of Porto AlegreOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT04432402 | Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma | unknown | N/A | 124 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04406285 | Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent. | unknown | N/A | 66 | Federal University of Health Science of Porto AlegreOTHER | 1 | May 28, 2020 | clinicaltrials |
| NCT04376957 | Pilot Study of an Oral Chemotherapy Teaching Tool to Improve Adherence in Patients With Multiple Myeloma | unknown | N/A | 60 | Hamilton Health Sciences CorporationOTHER | 0 | May 6, 2020 | clinicaltrials |
| NCT04367948 | Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma | unknown | N/A | 200 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT03260231 | Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma(Lymphoseed) | unknown | N/A | 40 | University of BelgradeOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT01953770 | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008(ALL-MB 2008) | unknown | N/A | 3,000 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 3 | Feb 5, 2020 | clinicaltrials |
| NCT03390387 | Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)(ALL-MB 2015) | unknown | N/A | 4,000 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 5 | Feb 5, 2020 | clinicaltrials |
| NCT04237428 | CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma | unknown | N/A | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Jan 23, 2020 | clinicaltrials |
| NCT04221620 | Effectiveness of EEG Neurofeedback in Pediatric Occupational Therapy to Improve Executive Functioning | unknown | N/A | 30 | Northern Arizona UniversityOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT04212858 | Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma | unknown | N/A | 100 | Assiut UniversityOTHER | 0 | Dec 30, 2019 | clinicaltrials |
| NCT04158414 | Applying PET/MR in Oncology - a Prospective Project | unknown | N/A | 500 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 8, 2019 | clinicaltrials |
| NCT04154228 | Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI | unknown | N/A | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04120896 | Karate or Kung Fu? | unknown | N/A | 52 | The University of Hong KongOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT04008888 | a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients | unknown | N/A | 50 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02861209 | Collaborative Network to Take Responsibility for Oral Anticancer Therapy(CONTACT) | unknown | N/A | 228 | KU LeuvenOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03704597 | Cryotherapy Against Oral Mucositis After High-dose Melphalan | unknown | N/A | 100 | Sahlgrenska University HospitalOTHER | 0 | Oct 15, 2018 | clinicaltrials |
| NCT03674710 | A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques(EUS-FNA) | unknown | N/A | 300 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT02800447 | Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol | unknown | N/A | 92 | Lee's Pharmaceutical LimitedINDUSTRY | 0 | Sep 4, 2018 | clinicaltrials |
| NCT03283111 | Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma | unknown | N/A | 150 | Peking UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03564977 | CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation | unknown | N/A | 20 | Qingdao Central HospitalOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT03556748 | WB-EMS and Nutrition in Patients With Hematological Malignancies | unknown | N/A | 40 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT03495492 | Chronic Lymphocytic Leukemia Responds to Dermal Chelation | unknown | N/A | 50 | Optimum Health, Natural Healthcare CenterOTHER | 0 | Apr 12, 2018 | clinicaltrials |
| NCT03488160 | CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma | unknown | N/A | 6 | Sinobioway Cell Therapy Co., Ltd.INDUSTRY | 1 | Apr 10, 2018 | clinicaltrials |
| NCT03462095 | De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL) | unknown | N/A | 350 | National Research Center for Hematology, RussiaNETWORK | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03373526 | Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation | unknown | N/A | 50 | Daniel Godoy MartinezOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03340155 | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases(BioUV2017) | unknown | N/A | 240 | Medical University of GrazOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT02345915 | Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia(LEA-JA) | unknown | N/A | 90 | Institut Paoli-CalmettesOTHER | 1 | Sep 5, 2017 | clinicaltrials |
| NCT03268889 | Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)(CHOP) | unknown | N/A | 39 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02728882 | Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma(EECBL) | unknown | N/A | 24 | Sinobioway Cell Therapy Co., Ltd.INDUSTRY | 1 | Mar 23, 2017 | clinicaltrials |
| NCT02087657 | Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation(Auto-HBO) | unknown | N/A | 20 | University of Kansas Medical CenterOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT03051542 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051555 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051568 | Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma | unknown | N/A | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT03051581 | 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma | unknown | N/A | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02572596 | Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients | unknown | N/A | 200 | Wang GuorongOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02916459 | EBUS-TBNA vs Flex 19G EBUS-TBNA | unknown | N/A | 250 | Heidelberg UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT03022123 | The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma | unknown | N/A | 270 | Hebei Medical University Fourth HospitalOTHER | 1 | Jan 16, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 9, 2020source: clinicaltrials